Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Owen

Showing results (61-70 of 460) with videos related to

Pageof 46
Sort By:
Health Physics|April 28, 2023
Reply to Amir Alexander BahadoriRobert Peter Gale, F Owen Hoffman
JAMA|April 16, 2020
Failing Another National Stress Test on Health DisparitiesWilliam F Owen, Richard Carmona, Claire Pomeroy
The New England Journal of Medicine|August 28, 1980
Angiotensin-converting enzyme in substantia nigra of schizophrenicsF Owen, R Lofthouse, T J Crow
Acta Psychiatrica Belgica|September 1, 1987
Central dopaminergic mechanisms in schizophreniaF Owen, T J Crow, M Poulter
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 9, 2004
Permanent gentamicin vestibulotoxicityF Owen Black, Susan Pesznecker, Valerie Stallings
Journal of the American Society of Nephrology : JASN|June 1, 2002
Perception versus reality of the burden of chronic kidney disease in the United StatesJoseph Coladonato, Preston Klassen, William F Owen
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 2, 1979
A radioreceptor assay for diazepam and its metabolites in serumF Owen, R Lofthouse, R C Bourne
Psychological Medicine|August 1, 1975
Platelet monoamine oxidase activity during the course of a schizophreniform psychosisI B Cookson, F Owen, A P Ridges
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1996
An observational study of cardiovascular characteristics of long-term end-stage renal disease survivorsW F Owen, F Madore, B M Brenner
Clinical Chemistry|May 1, 1973
Automated atomic absorption spectrophotometryH J Gitelman, C Soucek, J F Owen
Pageof 46

Showing results (61-70 of 460) with videos related to

Sort By:
Pageof 46
Health Physics|April 28, 2023
Reply to Amir Alexander BahadoriRobert Peter Gale, F Owen Hoffman
JAMA|April 16, 2020
Failing Another National Stress Test on Health DisparitiesWilliam F Owen, Richard Carmona, Claire Pomeroy
The New England Journal of Medicine|August 28, 1980
Angiotensin-converting enzyme in substantia nigra of schizophrenicsF Owen, R Lofthouse, T J Crow
Acta Psychiatrica Belgica|September 1, 1987
Central dopaminergic mechanisms in schizophreniaF Owen, T J Crow, M Poulter
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 9, 2004
Permanent gentamicin vestibulotoxicityF Owen Black, Susan Pesznecker, Valerie Stallings
Journal of the American Society of Nephrology : JASN|June 1, 2002
Perception versus reality of the burden of chronic kidney disease in the United StatesJoseph Coladonato, Preston Klassen, William F Owen
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 2, 1979
A radioreceptor assay for diazepam and its metabolites in serumF Owen, R Lofthouse, R C Bourne
Psychological Medicine|August 1, 1975
Platelet monoamine oxidase activity during the course of a schizophreniform psychosisI B Cookson, F Owen, A P Ridges
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1996
An observational study of cardiovascular characteristics of long-term end-stage renal disease survivorsW F Owen, F Madore, B M Brenner
Clinical Chemistry|May 1, 1973
Automated atomic absorption spectrophotometryH J Gitelman, C Soucek, J F Owen
Pageof 46